Literature DB >> 7819050

Alternative therapeutic options in patients with advanced gastrointestinal cancer.

G C Wishart, T G Cooke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7819050      PMCID： PMC2033443          DOI： 10.1038/bjc.1995.2

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  23 in total

1.  Effect of cimetidine on survival after gastric cancer.

Authors:  H Tønnesen; U Knigge; S Bülow; P Damm; K Fischerman; P Hesselfeldt; A Hjortrup; I K Pedersen; V M Pedersen; O J Siemssen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

Review 2.  Oncological applications of somatostatin analogues.

Authors:  A V Schally
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

3.  New aspects of the trophic action of gastrointestinal hormones.

Authors:  L R Johnson
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

4.  Effects of a somatostatin analogue (SMS 201-995) on the growth and development of hepatic tumour derived by intraportal injection of Walker cells in the rat.

Authors:  D M Nott; J Y Baxter; J S Grime; D W Day; T G Cooke; S A Jenkins
Journal:  Br J Surg       Date:  1989-11       Impact factor: 6.939

5.  Somatostatin receptors in human colorectal cancer.

Authors:  S Y Iftikhar; W M Thomas; P S Rooney; D L Morris
Journal:  Eur J Surg Oncol       Date:  1992-02       Impact factor: 4.424

6.  SMS 201.995 inhibits in vitro and in vivo growth of human colon cancer.

Authors:  D Y Dy; R H Whitehead; D L Morris
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

7.  Cancer risk following pernicious anaemia.

Authors:  L A Brinton; G Gridley; Z Hrubec; R Hoover; J F Fraumeni
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

8.  Co-stimulation of gastrointestinal tumour cell growth by gastrin, transforming growth factor alpha and insulin like growth factor-I.

Authors:  L G Durrant; S A Watson; A Hall; D L Morris
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

9.  Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.

Authors:  J G Klijn; A M Hoff; A S Planting; J Verweij; T Kok; S W Lamberts; H Portengen; J A Foekens
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

10.  Somatostatin binding in normal and malignant human gastrointestinal mucosa.

Authors:  G V Miller; S M Farmery; L F Woodhouse; J N Primrose
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.